VITA 34 International AG: General Meeting approves all items on the agenda with more than 99 percent
VITA 34 International AG / AGM/EGM Release of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer / publisher is solely responsible for the content of this announcement. ---------------------------------------------------------------------- Leipzig, 15 July 2009 - The shareholders of VITA 34 International AG (ISIN DE000A0BL849), the holding company of the leading umbilical cord blood bank within the German-speaking area VITA 34, have approved all the items on the agenda with more than 99 percent during today's General Meeting of shareholders. Among other things, the management and the supervisory board were granted formal approval for the financial year 2008. In addition, the General Meeting of shareholders resolved to reduce the supervisory board from six to three members. Richard J. Neeson, Senior Vice President of the corporation's principal shareholder Independence Blue Cross and Dr. Uwe Marx, CSO of the Probiogen AG, were confirmed as members of the supervisory board. Dr. Holger Födisch, CEO of the Dr. Födisch Umweltmesstechnik AG, was newly elected as a member of the supervisory board. A total of up to 69 percent of the share capital were present at the General Meeting of shareholders. Press/ Investor Relations: Axel Mühlhaus Dr. Sönke Knop edicto GmbH Zeißelstraße 19 D-60318 Frankfurt Phone: +49 (069) 90550550 Fax: +49 (069) 90550577 E-mail: vita34@edicto.de 15.07.2009 Financial News transmitted by DGAP ---------------------------------------------------------------------- Language: English Issuer: VITA 34 International AG Deutscher Platz 5a 04103 Leipzig Deutschland Phone: +49(0341)48792-40 Fax: +49(0341)48792-39 E-mail: info@vita34.de Internet: www.vita34.de ISIN: DE000A0BL849 WKN: A0BL84 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, München, Hamburg, Stuttgart End of News DGAP News-Service ---------------------------------------------------------------------------